Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIII.
Reding MT, Ng HJ, Poulsen LH, Eyster ME, Pabinger I, Shin HJ, Walsch R, Lederman M, Wang M, Hardtke M, Michaels LA.
Reding MT, et al. Among authors: michaels la.
J Thromb Haemost. 2017 Mar;15(3):411-419. doi: 10.1111/jth.13597. Epub 2017 Feb 22.
J Thromb Haemost. 2017.
PMID: 27992112
Free article.
Clinical Trial.